stockrow
Thursday 12 November 2026
Export INCY’s income statement to Excel — free account
Incyte Corporation
INCYIncyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.
- Revenue
- +14.0%
- EPS
- −277.9%
- Free cash flow
- −233.0%
- Total debt
- −10.5%
Quarter to September 2026, against a year earlier
121.89
0.38
−0.31%
Follow INCY
Alert me
Incyte Corporation (INCY) Operating margin
Incyte Corporation's operating margin over the twelve months to 30 September 2026 was 10.4%, down 19.0 percentage points from fiscal 2025 (29.5%). Over the past ten years it has ranged from −15.8% (fiscal 2017) to 29.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 29.5% | 28.01 |
| FY2024 | 1.45% | (15.34) |
| FY2023 | 16.8% | (0.28) |
| FY2022 | 17.1% | (2.55) |
| FY2021 | 19.6% | 29.51 |
| FY2020 | −9.89% | (28.51) |
| FY2019 | 18.6% | 11.75 |
| FY2018 | 6.87% | 22.71 |
| FY2017 | −15.8% | (28.95) |
| FY2016 | 13.1% | 6.39 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −45.5% | (87.18) |
| Jun 2026 | 41.7% | 18.03 |
| Mar 2026 | 23.7% | 1.37 |
| Dec 2025 | 22.3% | (10.18) |
| 43 more quarters | Free account |
Against its own ten years
Low −15.8%
High 29.5%
Ten-year median
13.1%
Current reading's percentile
40
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| GMAB Genmab A/S Sponsored ADR compare | 24.3% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| INCY Incyte Corporation | 10.4% |
| JAZZ Jazz Pharmaceuticals PLC compare | 9.03% |
| INSM Insmed, Inc. compare | −37.1% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| ROIV Roivant Sciences Ltd. compare | −1,358.2% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on INCY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement